(Q27307203)

Ben S Cooper

4

0 references

Gabriel Leung

Gabriel M Leung

2

0 references

Steven Riley

Steven Riley

5

0 references

Joseph T Wu

1

Creative Commons Attribution 4.0 International

Joseph T Wu

0 references

language of work or name

English

0 references

publication date

19 May 2009

0 references

published in

PLOS MEDICINE

0 references

volume

6

0 references

issue

5

0 references

page(s)

e1000085

0 references

copyright license

start time

19 May 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Antiviral resistance and the control of pandemic influenza

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Transmissibility of 1918 pandemic influenza

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Enhancement of activity against influenza viruses by combinations of antiviral agents

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Reducing the impact of the next influenza pandemic using household-based public health interventions

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Strategies for mitigating an influenza pandemic

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Strategies for containing an emerging influenza pandemic in Southeast Asia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Oseltamivir-resistant influenza a viruses circulating in Japan

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Global transmission of oseltamivir-resistant influenza

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Developing new antiviral agents for influenza treatment: what does the future hold?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Neuraminidase inhibitor resistance in influenza viruses.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Delaying the international spread of pandemic influenza.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Emergence of drug-resistant influenza virus: population dynamical considerations.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Mitigation strategies for pandemic influenza in the United States.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Containing pandemic influenza at the source.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Emergence of drug resistance during an influenza epidemic: insights from a mathematical model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

John F. Enders lecture 2006: antivirals for influenza.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680070

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

31 May 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000085

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000085

Emergence of drug resistance: implications for antiviral control of pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000085

What is the best control strategy for multiple infectious disease outbreaks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000085

Synchrony, waves, and spatial hierarchies in the spread of influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000085

Update: influenza activity--United States, September 30, 2007-February 9, 2008.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19440354

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19440354

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Zanamivir treatment is equally effective for both influenza A and influenza B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19440354